Both in Blank Checks
Translational Development Acquisition vs Market Technology Acquisition
Over the past year TDAC returned −0.2% and MTAK returned −0.6%; their daily moves had a correlation of 0.07.
TDAC −0.2% MTAK −0.6%Growth of $1, one year, split-adjusted
| Metric | TDAC | MTAK |
|---|---|---|
| Price | $10.85 | $9.86 |
| Market cap | $209.5M | $209.2M |
| Today | +0.09% | 0.00% |
| 1 month | −0.2% | +0.1% |
| 6 months | +2.1% | — |
| Year to date | +3.4% | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 37.8× | — |
| Price / sales | — | — |
| Net cash | -$1.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 2.4% | — |
| Short % of float | 0.0% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).